Thalidomide, an antiangiogenic agent with clinical activity in cancer
Despite the teratogenic past of thalidomide, there is recent evidence indicating the drug’s efficacy in the management of various diseases from immune disorders to cancers. The history, pharmacodynamic and pharmacokinetic properties of thalidomide in the clinic are discussed in this review article....
Saved in:
Published in | Biomedicine & Pharmacotherapy Vol. 56; no. 4; pp. 194 - 199 |
---|---|
Main Authors | , , |
Format | Book Review Journal Article |
Language | English |
Published |
Paris
Elsevier SAS
01.06.2002
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Despite the teratogenic past of thalidomide, there is recent evidence indicating the drug’s efficacy in the management of various diseases from immune disorders to cancers. The history, pharmacodynamic and pharmacokinetic properties of thalidomide in the clinic are discussed in this review article. |
---|---|
ISSN: | 0753-3322 1950-6007 |
DOI: | 10.1016/S0753-3322(02)00177-4 |